About the Event
If you live with food allergies, you live in fear. With every meal, every snack, and every bite comes the opportunity for exposure to an ingredient that can be life-threatening. Peanuts, shellfish, milk, soy, and other foods cause everything from minor irritations like tingling, itching, and rashes, to anaphylactic shock that leads to death. The fear is real for not only over 30 million Americans, but their entire families.
Intrommune Therapeutics is transforming and protecting the lives of more than 220 million people with food allergies by delivering immunotherapeutic agents in specially formulated toothpaste. This new approach for the treatment of food allergies is called oral mucosal immunotherapy (OMIT) and addresses a significant health care need in the industrialized world, where the spread of food allergies has been characterized as an “epidemic.”
Join our webinar to hear from Intrommune Therapeutics CEO, Michael Nelson. He’ll discuss how the company’s technology will transform lives by allowing children and adults with food allergies to no longer live in fear of accidentally eating peanuts, shellfish, soy, gluten or other problem foods, simply by brushing their teeth.